IRIS
NICOLETTI, FERDINANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.229
EU - Europa 7.704
AS - Asia 6.988
SA - Sud America 1.429
AF - Africa 838
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 34.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.644
SG - Singapore 3.826
RU - Federazione Russa 2.356
CN - Cina 2.187
IT - Italia 1.574
IE - Irlanda 1.356
BR - Brasile 1.263
UA - Ucraina 1.227
CA - Canada 489
CI - Costa d'Avorio 476
DE - Germania 296
VN - Vietnam 288
SE - Svezia 236
SN - Senegal 181
GB - Regno Unito 161
KR - Corea 139
IN - India 114
MX - Messico 71
AR - Argentina 64
NL - Olanda 64
FR - Francia 63
PL - Polonia 60
BD - Bangladesh 59
JP - Giappone 58
ZA - Sudafrica 51
FI - Finlandia 48
UZ - Uzbekistan 43
EC - Ecuador 38
KE - Kenya 38
TR - Turchia 37
CH - Svizzera 36
EE - Estonia 36
HK - Hong Kong 34
IR - Iran 34
AT - Austria 33
IQ - Iraq 33
ES - Italia 32
BG - Bulgaria 25
ID - Indonesia 24
BE - Belgio 23
GR - Grecia 18
NG - Nigeria 18
MA - Marocco 16
EU - Europa 15
PK - Pakistan 15
AU - Australia 14
BJ - Benin 14
TN - Tunisia 14
VE - Venezuela 14
AE - Emirati Arabi Uniti 12
LB - Libano 12
PY - Paraguay 12
CO - Colombia 11
IL - Israele 11
LT - Lituania 11
PE - Perù 11
RO - Romania 10
EG - Egitto 8
GE - Georgia 8
SA - Arabia Saudita 8
CL - Cile 7
DO - Repubblica Dominicana 7
MY - Malesia 7
UY - Uruguay 7
DZ - Algeria 6
JO - Giordania 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
PH - Filippine 5
PT - Portogallo 5
BH - Bahrain 4
ET - Etiopia 4
HN - Honduras 4
KZ - Kazakistan 4
MK - Macedonia 4
NP - Nepal 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
JM - Giamaica 2
KH - Cambogia 2
LI - Liechtenstein 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TO - Tonga 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 34.205
Salva come PNG Salva come JPEG
Città #
Dallas 4.740
Singapore 2.084
Santa Clara 1.721
Jacksonville 1.455
Dublin 1.354
Chandler 1.314
Moscow 988
Boardman 647
Catania 528
Chicago 516
Ashburn 510
Abidjan 476
Lawrence 376
Cambridge 373
Hefei 368
Andover 367
Nanjing 362
Toronto 333
Houston 318
Beijing 292
Los Angeles 246
Des Moines 226
San Mateo 194
Dakar 181
Civitanova Marche 165
Wilmington 147
Seoul 137
Nanchang 128
Grafing 124
São Paulo 123
New York 122
The Dalles 105
Columbus 100
Hebei 97
Saint Petersburg 92
Council Bluffs 86
Ho Chi Minh City 85
Ottawa 79
Jiaxing 78
Shenyang 77
Buffalo 75
Tianjin 64
Changsha 60
Rome 56
Tokyo 53
Brooklyn 51
Hanoi 51
Bremen 46
Dong Ket 46
Palermo 45
Orem 44
Amsterdam 43
San Jose 39
Boston 37
Montreal 37
Warsaw 37
San Francisco 36
Johannesburg 35
Milan 35
Rio de Janeiro 35
Seattle 35
Denver 33
Falls Church 33
Guangzhou 33
Phoenix 33
Atlanta 32
Lappeenranta 32
Stockholm 31
London 30
Munich 30
Belo Horizonte 29
Hangzhou 27
Hong Kong 27
Norwalk 27
Messina 26
Brussels 23
Washington 23
Nizza di Sicilia 22
Poplar 22
Pune 22
Jinan 21
Mumbai 21
Jakarta 20
Kunming 20
Sant'Antonio Abate 20
Vercelli 20
Curitiba 19
Abuja 18
Augusta 18
Brasília 18
Dearborn 18
Acireale 17
Campinas 17
Chennai 17
Den Haag 17
Redondo Beach 17
Salvador 17
Tappahannock 17
Ardabil 16
Haiphong 16
Totale 23.573
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 397
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 266
Advances in targeting signal transduction pathways. 224
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 224
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 201
Ageing: from inflammation to cancer. 198
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 193
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 189
Akt as a therapeutic target in cancer 181
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 180
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 177
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 176
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 171
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 169
(S,R)-3-Phenyl-4,5 dihydro-5-isoxazole acetic acid – nitric oxide and use thereof as anti-cancer and antiviral agent 167
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 163
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 162
(S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid–Nitric Oxide (GIT-27NO) – New Dress for Nitric Oxide Mission 161
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 160
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 159
CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes 157
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 157
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 156
Characterization of the pathophysiological role of CD47 in uveal melanoma 156
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 156
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 148
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 147
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 146
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 145
CORRELATION BETWEEN ISLET CELL ANTIBODIES AND ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES IN HEALTHY 1ST-DEGREE RELATIVES OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS 144
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 143
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 143
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 143
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 143
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 141
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 141
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 140
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 139
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 139
Emerging Raf inhibitors 138
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide 138
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 137
Emerging therapeutic targets for the treatment of hepatic fibrosis 136
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 136
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 136
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 135
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 135
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 135
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 133
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 133
ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES, ISLET CELL ANTIBODIES AND GAMMA-INTERFERON SERUM LEVELS IN NEWLY DIAGNOSED IDDM PATIENTS 133
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells 133
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies 132
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 132
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 131
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 129
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 129
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 129
. Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type 1 128
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 128
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 127
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 127
A randomised, double blind, placebo-controlled trial on the effect of Fusidin in patients with newly diagnosed Type 1 diabetes: the FUSIDM tria 126
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 126
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 126
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 126
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10 125
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 124
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 123
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo 122
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 122
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 121
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 121
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 120
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 117
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat 117
Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases 117
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells 116
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia 115
Vitamin D3: a helpful immuno-modulator 115
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 115
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 114
mTOR as a multifunctional therapeutic target in HIV infection 114
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 113
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome 113
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 113
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 113
Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures 112
Effects of Tumour Necrosis Factor-alpha on Human Sperm Motility and Apoptosis 112
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 111
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 111
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 111
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells 111
). NO-hybridized protease inhibitors as a new class of anticancer compounds. Saquinavir-NO as prototypical example?. 111
EFFECTS OF OCTREOTIDE ON THE GLYCEMIC LEVELS IN INSULIN-DEPENDENT DIABETIC-PATIENTS - COMPARATIVE-STUDY BETWEEN ADMINISTRATION THROUGH MULTIPLE SUBCUTANEOUS INJECTIONS AND CONTINUOUS SUBCUTANEOUS INFUSION 110
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo 110
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 110
Epilepsy and multiple sclerosis 109
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 109
Emerging MEK inhibitors 109
Totale 14.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.217 0 0 0 0 0 52 293 11 302 15 419 125
2021/20222.787 323 378 4 53 433 57 395 92 249 8 71 724
2022/20234.324 405 153 55 373 420 790 19 761 1.053 60 128 107
2023/20241.767 117 243 86 170 64 390 12 120 10 75 277 203
2024/20257.301 63 1.073 465 296 1.726 639 228 344 564 741 652 510
2025/202612.791 1.001 2.800 3.071 1.029 2.262 2.628 0 0 0 0 0 0
Totale 34.779